Thus, this review critically examines the literature on the comparative role of GPER in DM and malignancies, highlighting research gaps that need to be addressed and pointing to the potential of GPER as a therapeutic target for the management of both DM and malignancy. Here, GPER1 is linked to diabetes mellitus.